Announcement of Fosun Pharmaceutical on the acceptance of drug registration applications by holding subsidiaries
Announcement of Fosun Pharmaceutical on the approval of its holding subsidiary for drug clinical trials
Fosun Pharmaceuticals Board of Directors Rules of Procedure (2024 Revision)
Fosun Pharmaceuticals: Legal Opinion of Guohao Lawyers (Shanghai) Firm on the 2024 First Extraordinary General Meeting of Shareholders of Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Announcement of Resolutions of Fosun Pharmaceutical\'s 2024 First Extraordinary General Meeting of Shareholders
Fosun Pharmaceuticals: Fosun Pharmaceutical\'s Announcement on the Implementation of Repurchase and Cancellation of Some A-Share Restricted Shares
Fosun Pharmaceutical: Fosun Pharmaceutical\'s announcement on the implementation results of the A-share repurchase and changes in the share structure
Fosun Pharmaceutical: Fosun Pharmaceutical\'s Prompt Announcement on Convening the 2024 First Extraordinary General Meeting of Shareholders
Fosun Pharmaceutical\'s indicative announcement on holding the 2024 First Extraordinary General Meeting of Shareholders
Fosun Pharmaceutical\'s announcement on the resignation of senior management
Announcement of Fosun Pharmaceutical on the acceptance of drug registration applications by holding subsidiaries
Fosun Pharmaceutical\'s announcement on the progress of initiating the establishment of a private equity investment fund
Fosun Pharmaceutical\'s announcement on the approval of licensed products for drug registration
Fosun Pharmaceutical\'s Announcement on New and Renewal Loans and Related Transactions by Holding Subsidiaries
Fosun Pharmaceutical\'s announcement on the progress of initiating the establishment of a private equity investment fund
Announcement of Fosun Pharmaceutical on the approval of its holding subsidiary for drug clinical trials
Fosun Pharmaceutical\'s announcement on the progress of the private equity investment fund initiated and related transactions
Fosun Pharmaceutical 2024 Semi-Annual Internal Control Evaluation Report
Fosun Pharmaceutical\'s announcement on the holding subsidiary\'s intention to implement follow-up investment and initial incentive plans and related transactions
Announcement on the progress of the merger and privatization of Shanghai Henlius Biotech Co., Ltd., a subsidiary of Fosun Pharma
No Data
No Data